The Latest in ALL

All cases of CRS are not created equal

December 30, 2016

KTE-C19 feasible in most young, high-risk ALL patients, study suggests

December 23, 2016

Intermittent fasting fights ALL, not AML, in mice

December 21, 2016

Congenital CMV linked to increased risk of ALL

December 16, 2016

Platform could optimize treatment of ALL, other diseases

December 15, 2016

How old is too old to be on a kids’ protocol for ALL?

December 14, 2016

Group estimates global cancer cases, deaths in 2015

December 8, 2016

FDA grants full approval for ponatinib

November 30, 2016

CAR T-cell trial placed on hold again

November 25, 2016

ALL subtype ‘highly prevalent’ in adults

November 22, 2016

Team develops model of common infant ALL

November 16, 2016

Company withdraws application for eryaspase in ALL

November 16, 2016

Panobinostat might treat high-risk ALL subtype

November 9, 2016

Combo shows promise for treating T-ALL

October 31, 2016

Team identifies genetic hallmarks of B-ALL subtype

October 26, 2016